Literature DB >> 35879356

Positive phase III results for odevixibat for progressive familial intrahepatic cholestasis.

Katrina Ray1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35879356     DOI: 10.1038/s41575-022-00667-x

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN: 1759-5045            Impact factor:   73.082


× No keyword cloud information.
  1 in total

1.  Odevixibat treatment in progressive familial intrahepatic cholestasis: a randomised, placebo-controlled, phase 3 trial.

Authors:  Richard J Thompson; Henrik Arnell; Reha Artan; Ulrich Baumann; Pier Luigi Calvo; Piotr Czubkowski; Buket Dalgic; Lorenzo D'Antiga; Özlem Durmaz; Björn Fischler; Emmanuel Gonzalès; Tassos Grammatikopoulos; Girish Gupte; Winita Hardikar; Roderick H J Houwen; Binita M Kamath; Saul J Karpen; Lise Kjems; Florence Lacaille; Alain Lachaux; Elke Lainka; Cara L Mack; Jan P Mattsson; Patrick McKiernan; Hasan Özen; Sanjay R Rajwal; Bertrand Roquelaure; Mohammad Shagrani; Eyal Shteyer; Nisreen Soufi; Ekkehard Sturm; Mary Elizabeth Tessier; Henkjan J Verkade; Patrick Horn
Journal:  Lancet Gastroenterol Hepatol       Date:  2022-07-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.